Overview
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2024 – the filing deadline has passed. 4 of 6 financial statements were filed late (the longest delay 501 days for 2018). 3 of 6 audited by a statutory auditor.
- 2024not filed
- 202319/07/2024
- 202218/10/2023
- 202114/07/2022
- 202005/10/2021
- 201927/11/2020
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2021.
Results vs industry
Industry
Trademarks
The company currently holds no active trademarks with the Polish Patent Office. 4 marks have expired or were not registered. The first mark was filed in 2014.
| Mark | Protected until | |
|---|---|---|
| Panel odkleszczowy (word) | – | |
| Panel 170 Plus (word) | – | |
| Panel koinfekcji (word) | – | |
| Centrum Badań DNA Laboratorium Genetyki Medycznej cbdna.pl | – |
Authorized Representatives
Manner of representation
The following is authorized to submit declarations of will on behalf of the company: A. the President of the Management Board – individually; B. the other members of the management board – acting jointly with the President of the Management Board or a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 814 | $164,910.86 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Medgenetics sp. z o.o. | 2,701.24 USD | 100% | ||
Genetyka Plus sp. z o.o. | 324.15 USD | 24% |
Bank accounts
Was a VAT taxpayer from 2006-07-12 to 2025-11-13.
Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)
Debt
10 closed proceedings recorded in KRZ history.
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Jul 8, 2026 | Discontinued enforcement proceedings | Closed | |
| Jun 17, 2026 | Discontinued enforcement proceedings | Closed | |
| Jun 12, 2026 | Discontinued enforcement proceedings | Closed | |
| Dec 6, 2025 | Discontinued enforcement proceedings | Closed | |
| Nov 28, 2025 | Discontinued enforcement proceedings | Closed |
Public aid
5 public aid cases recorded, with a total value of $887,204.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 22, 2018 | Aid for research and development projects: industrial research | $227.5K$227,487 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Jun 22, 2018 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $138.5K$138,547 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Jun 22, 2018 | Aid for research and development projects: experimental development | $84,892$84,892 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Medapp S.A. | $3,351,163.61 | medapp.pl | ||
| Biotechna S.A. | $2,472,888.07 | bsbiotechna.com | ||
| Genxone S.A. | $665,361.35 | genxone.eu | ||
| Polbiotech Laboratorium sp. z o.o. | $645,943.81 | polbiotech.pl | ||
| Relvo sp. z o.o. | $120,693.26 | relvo.pl | ||
| Microblic sp. z o.o. | $122,383.50 | microblic.pl | ||
| Xenstats sp. z o.o. | $66,774.27 | xenstats.com | ||
| Fungotech sp. z o.o. | $187.68 | fungo.tech | ||
| Dystrogen Therapeutics S.A. | – | dystrogen.com | ||
| MIMO Biotech P.S.A. | – | mimobiotech.com |
Change history
| Date | Event | |
|---|---|---|
| 2020-09-21 | Address change (Poznań → Ul. Piotra Ściegiennego 20, 60-128, Poznań) | |
| 2019-07-08 | Address change (Ul. Inflancka 25, 61-132, Poznań → Poznań) | |
| 2018-05-25 | Address change (Rubież 46, 61-612, Poznań → Ul. Inflancka 25, 61-132, Poznań) | |
| 2016-05-09 | PKD change (Removed: 33 codes) | |
| 2012-02-29 | Share capital increase (150,000.00 PLN → 610,500.00 PLN) |
FAQ
Last updated: 2026-10-07